Isofol Medical AB (publ) announced that the company has taken notice of the results from the investigator-initiated study Modelle 001. As previously informed, Sahlgrenska University Hospital in collaboration with Norrland University Hospital has conducted an investigator-initiated academic study, Modelle 001. The study included 30 patients and was led by Dr. Helena Taflin at Sahlgrenska University hospital in Gothenburg.

The aim of the study was to examine in detail the effect of different folates (arfolitixorin/leucovorin) in combination with 5-FU on patients with colorectal cancer that has metastasized to the liver. The research team presented the final study results at the Folate Receptor Society's 8th International Symposium on Folate Biology and Therapeutics in New York on 4 October 2023.